Layer 1

Two strengths of ranitidine among 22 price concessions for November

The Department of Health and Social Care (DH) and the National Assembly for Wales have agreed concessionary prices for the following 22 items for November 2019 prescriptions.

An initial nine price concessions for the month were announced on November 19.

Drug
Strength
Form
Price
Amiloride
5mg
tablets (28)
£19.50
Bumetanide
1mg
tablets (28)
£1.95
Co-careldopa
25mg/100mg
tablets (100)
£11.99
Dexamfetamine
5mg/5ml
sugar-free oral solution (500)
£381.63
Indapamide
2.5mg
tablets (28)
£2.20
Irbesartan
75mg
tablets (28)
£3.44
Irbesartan
150mg
tablets (28)
£6.33
Irbesartan
300mg
tablets (28)
£6.93
Levetiracetam
1g
tablets (60)
£12.50
Meloxicam
15mg
tablets (30)
£5.55
Memantine
10mg
tablets (28)
£3.30
Nefopam
30mg
tablets (90)
£7.99
Nifedipine
5mg
capsules (90)
£51.95
Nifedipine
10mg
capsules (90)
£65.63
Nitrofurantoin
100mg
tablets (28)
£10.68
Nizatidine
150mg
capsules (30)
£7.99
Oxytetracycline
250mg
tablets (28)
£4.99
Propranolol
10mg
tablets (28)
£2.00
Propranolol
40mg
tablets (28)
£2.00
Quinine sulfate
300mg
tablets (28)
£5.90
Ranitidine
150mg
tablets (60)
£4.07
Ranitidine
300mg
tablets (30)
£3.85

Certain batches of ranitidine-containing medicines have been subject to recall and quarantine, as the Medicines and Healthcare products Regulatory Agency (MHRA) investigates their potential contamination with N-nitrosodimethylamine (NDMA), which is a known risk factor for some cancers. 

Last week (November 19), the MHRA announced the latest ranitidine-containing products to be recalled: Creo Pharma Limited's ranitidine oral solution 30mg/ml and Tillomed Laboratories Limited's ranitidine 150mg tablets.

0 Comments
Question: 
Do these prices reflect the ones you have paid in November so far?
Login or register to post comments

Job of the week

Pharmacy Manager
Macclesfield, Cheshire
Competitive